APA (7th ed.) Citation

Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., . . . Stankoff, B. (2022). Impact of methodological choices in comparative effectiveness studies: Application in natalizumab versus fingolimod comparison among patients with multiple sclerosis. BMC Medical Research Methodology, 22(1), 1. https://doi.org/10.1186/s12874-022-01623-8

Chicago Style (17th ed.) Citation

Lefort, M., et al. "Impact of Methodological Choices in Comparative Effectiveness Studies: Application in Natalizumab Versus Fingolimod Comparison Among Patients with Multiple Sclerosis." BMC Medical Research Methodology 22, no. 1 (2022): 1. https://doi.org/10.1186/s12874-022-01623-8.

MLA (9th ed.) Citation

Lefort, M., et al. "Impact of Methodological Choices in Comparative Effectiveness Studies: Application in Natalizumab Versus Fingolimod Comparison Among Patients with Multiple Sclerosis." BMC Medical Research Methodology, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12874-022-01623-8.